Metropolis Healthcare Limited

NSE: METROPOLIS · Healthcare

Overview

Metropolis Healthcare Limited Share Price & Analysis

₹568.8▼ -0.86%Updated 21 Jul 2026, 05:01 pm IST
LTP
₹568.8
-0.86%
Open
₹—
High
₹573
Low
₹562.5
Close
₹568.8
52W High
₹600
52W Low
₹412
Volume
93K
Lot Size
1
Sector
Healthcare
Market Cap
₹11K Cr
Face Value
₹2
Mid Cap

Price Chart

Fundamentals

P/E
57.6
Sector P/E
54.4
P/B
7.79
EPS
₹8.12
ROE
13.8%
ROCE
17.8%
D/E Ratio
0.15
Div Yield
0.37%
Book Value
₹73
+

Strengths

  • ✓Efficient capital deployment (ROCE 17.8%)
  • ✓Low debt relative to equity (D/E 0.2x)

Peer Comparison

CompanyCMPMkt CapP/EP/BROE %ROCE %D/E
SUNPHARMA
Sun Pharmaceutical Industries Limited
₹1,944
₹4.6L Cr37.35.591620.50.07
DIVISLAB
Divi's Laboratories Limited
₹7,388
₹1.9L Cr73.411.7116.5220.01
TORNTPHARM
Torrent Pharmaceuticals Limited
₹5,040
₹1.6L Cr73.620.3227.415.20.33
APOLLOHOSP
Apollo Hospitals Enterprise Limited
₹8,939
₹1.3L Cr64.913.5622.117.90.88
CIPLA
Cipla Limited
₹1,416
₹1.1L Cr30.13.3211.615.50.01
ZYDUSLIFE
Zydus Lifesciences Limited
₹1,123
₹1.1L Cr214.1721.221.10.38
LUPIN
Lupin Limited
₹2,405
₹1.1L Cr19.64.928.729.90.32

Showing 7 peers in the same sector · Sorted by market cap

Shareholding Pattern

METROPOLIS · as of Mar 2026

Promoters48.89%▼0.51
FII15.29%▼1.44
DII30.30%▲0.30
Public5.51%▲1.65
CategoryDec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Promoters49.74%49.67%49.62%49.43%49.40%48.89%
FII21.66%18.90%18.25%18.56%16.73%15.29%
DII20.73%24.86%27.42%28.02%30.00%30.30%
Public7.87%6.57%4.69%3.98%3.86%5.51%

Corporate Events

Interim Dividend - Re 1 Per Share

Dividend18 May 2026

To consider and approve the audited financial results of the company for the quarter and financial year ended March 31, 2026 and dividend

Dividend12 May 2026

Bonus 3:1

Bonus19 Mar 2026

Interim Dividend - Rs 4 Per Share

Dividend10 Nov 2025

Interim Dividend - Rs 4 Per Share

Dividend16 Nov 2023

Annual General Meeting

AGM9 Aug 2023

Latest News

All news →

Metropolis Healthcare allots 36,900 stock units

*Metropolis Healthcare allots 36,900 equity shares under its 2020 stock unit plan.* The allotment is part of the company's restricted stock unit scheme. This move supports employee retention and performance incentives. No immediate financial impact is expected. 📊 *STOCKS:* METROPOLIS | 🏢 *SECTOR:* Healthcare | #LOWIMPACT #StockUnits

NSE Filing9 Jul
Low Impact

Financials

Quarterly Results

MetricDec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024
Revenue
₹406 Cr
▼5.4%
₹429 Cr
▲11.1%
₹386 Cr
▲11.9%
₹345 Cr
▲6.8%
₹323 Cr
▼7.7%
₹350 Cr
▲11.8%
₹313 Cr
▼5.4%
₹331 Cr
Op. Profit
₹95 Cr
▼12.0%
₹108 Cr
▲20.0%
₹90 Cr
▲45.2%
₹62 Cr
▼13.9%
₹72 Cr
▼20.0%
₹90 Cr
▲13.9%
₹79 Cr
▼1.3%
₹80 Cr
OPM
23.0%
▼8.0%
25.0%
▲8.7%
23.0%
▲27.8%
18.0%
▼18.2%
22.0%
▼15.4%
26.0%
▲4.0%
25.0%
▲4.2%
24.0%
Net Profit
₹42 Cr
▼20.8%
₹53 Cr
▲17.8%
₹45 Cr
▲55.2%
₹29 Cr
▼6.5%
₹31 Cr
▼34.0%
₹47 Cr
▲23.7%
₹38 Cr
▲2.7%
₹37 Cr
EPS (₹)
2
▼21.3%
2.54
▲17.1%
2.17
▲53.9%
1.41
▼7.8%
1.53
▼32.6%
2.27
▲22.7%
1.85
▲3.9%
1.78

Values in ₹ Cr · Source: Screener.in

Annual Profit & Loss

MetricMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017
Revenue
₹1.6K Cr
▲23.7%
₹1.3K Cr
▲10.2%
₹1.2K Cr
▲5.2%
₹1.1K Cr
▼6.5%
₹1.2K Cr
▲23.0%
₹998 Cr
▲16.6%
₹856 Cr
▲12.5%
₹761 Cr
▲17.6%
₹647 Cr
▲18.7%
₹545 Cr
Expenses
₹1.2K Cr
▲21.7%
₹1.0K Cr
▲11.2%
₹920 Cr
▲7.6%
₹855 Cr
▼2.8%
₹880 Cr
▲24.3%
₹708 Cr
▲14.4%
₹619 Cr
▲10.7%
₹559 Cr
▲19.7%
₹467 Cr
▲15.3%
₹405 Cr
Op. Profit
₹401 Cr
▲30.2%
₹308 Cr
▲6.9%
₹288 Cr
▼1.7%
₹293 Cr
▼15.8%
₹348 Cr
▲20.0%
₹290 Cr
▲22.4%
₹237 Cr
▲16.7%
₹203 Cr
▲12.2%
₹181 Cr
▲29.3%
₹140 Cr
OPM
24.0%
▲4.3%
23.0%
▼4.2%
24.0%
▼7.7%
26.0%
▼7.1%
28.0%
▼3.4%
29.0%
▲3.6%
28.0%
▲3.7%
27.0%
▼3.6%
28.0%
▲7.7%
26.0%
Other Income
₹17 Cr
▲13.3%
₹15 Cr
▲66.7%
₹9 Cr
▼40.0%
₹15 Cr
▼55.9%
₹34 Cr
▲183.3%
₹12 Cr
▲170.6%
₹-17 Cr
▼312.5%
₹8 Cr
▲33.3%
₹6 Cr
▼84.6%
₹39 Cr
Interest
₹25 Cr
▲4.2%
₹24 Cr
▼14.3%
₹28 Cr
▼12.5%
₹32 Cr
▲28.0%
₹25 Cr
▲108.3%
₹12 Cr
▼7.7%
₹13 Cr
▲225.0%
₹4 Cr
▲0.0%
₹4 Cr
▲100.0%
₹2 Cr
Depreciation
₹134 Cr
▲22.9%
₹109 Cr
▲16.0%
₹94 Cr
▲5.6%
₹89 Cr
▲41.3%
₹63 Cr
▲37.0%
₹46 Cr
▲17.9%
₹39 Cr
▲95.0%
₹20 Cr
▲5.3%
₹19 Cr
▲11.8%
₹17 Cr
PBT
₹259 Cr
▲35.6%
₹191 Cr
▲9.1%
₹175 Cr
▼6.9%
₹188 Cr
▼35.8%
₹293 Cr
▲20.1%
₹244 Cr
▲44.4%
₹169 Cr
▼9.6%
₹187 Cr
▲14.0%
₹164 Cr
▲2.5%
₹160 Cr
Tax %
26.0%
▲8.3%
24.0%
▼7.7%
26.0%
▲8.3%
24.0%
▼11.1%
27.0%
▲8.0%
25.0%
▲4.2%
24.0%
▼29.4%
34.0%
▲6.3%
32.0%
▼3.0%
33.0%
Net Profit
₹191 Cr
▲30.8%
₹146 Cr
▲14.1%
₹128 Cr
▼10.5%
₹143 Cr
▼33.5%
₹215 Cr
▲17.5%
₹183 Cr
▲43.0%
₹128 Cr
▲3.2%
₹124 Cr
▲10.7%
₹112 Cr
▲4.7%
₹107 Cr
EPS (₹)
9.17
▲31.0%
7
▲12.2%
6.24
▼10.6%
6.98
▼33.3%
10.46
▲16.9%
8.95
▲42.3%
6.29
▲5.0%
5.99
▼78.1%
27.29
▲2.6%
26.61
Div Payout
55.0%
0.0%
▼100.0%
16.0%
▼44.8%
29.0%
▲52.6%
19.0%
▼13.6%
22.0%
▼31.3%
32.0%
▼41.8%
55.0%
0.0%
▼100.0%
49.0%

Values in ₹ Cr · Source: Screener.in

Balance Sheet

ItemSep 2025Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017
Liabilities
Equity Capital
₹10 Cr
▲0.0%
₹10 Cr
▲0.0%
₹10 Cr
▲0.0%
₹10 Cr
▲0.0%
₹10 Cr
▲0.0%
₹10 Cr
▲0.0%
₹10 Cr
▲0.0%
₹10 Cr
▲0.0%
₹10 Cr
▲0.0%
₹10 Cr
Reserves
₹1.4K Cr
▲7.6%
₹1.3K Cr
▲21.6%
₹1.1K Cr
▲11.0%
₹978 Cr
▲11.6%
₹876 Cr
▲25.9%
₹696 Cr
▲35.7%
₹513 Cr
▲25.7%
₹408 Cr
▲0.7%
₹405 Cr
▲29.0%
₹314 Cr
Borrowings
₹201 Cr
▼1.5%
₹204 Cr
▲3.6%
₹197 Cr
▼25.9%
₹266 Cr
▼29.8%
₹379 Cr
▲238.4%
₹112 Cr
▲67.2%
₹67 Cr
▲272.2%
₹18 Cr
▲1700.0%
₹1 Cr
▲0.0%
₹1 Cr
Other Liabilities
₹359 Cr
▲10.8%
₹324 Cr
▲27.6%
₹254 Cr
▲5.8%
₹240 Cr
▼6.3%
₹256 Cr
▲41.4%
₹181 Cr
▲13.1%
₹160 Cr
▲41.6%
₹113 Cr
▲2.7%
₹110 Cr
▼41.5%
₹188 Cr
Total Liabilities
₹2.0K Cr
▲7.2%
₹1.9K Cr
▲20.2%
₹1.5K Cr
▲3.5%
₹1.5K Cr
▼1.7%
₹1.5K Cr
▲52.1%
₹1.0K Cr
▲33.3%
₹750 Cr
▲36.4%
₹550 Cr
▲4.6%
₹526 Cr
▲2.7%
₹512 Cr
Assets
Fixed Assets
₹1.6K Cr
▲8.7%
₹1.4K Cr
▲22.9%
₹1.2K Cr
▲5.0%
₹1.1K Cr
▲5.9%
₹1.1K Cr
▲208.7%
₹343 Cr
▲15.9%
₹296 Cr
▲39.0%
₹213 Cr
▲2.9%
₹207 Cr
▲2.5%
₹202 Cr
CWIP
₹0 Cr
₹0 Cr
₹0 Cr
▼100.0%
₹20 Cr
▲233.3%
₹6 Cr
₹0 Cr
▼100.0%
₹3 Cr
▼50.0%
₹6 Cr
₹0 Cr
▼100.0%
₹1 Cr
Investments
₹21 Cr
▼70.4%
₹71 Cr
▲29.1%
₹55 Cr
▲266.7%
₹15 Cr
▼6.3%
₹16 Cr
▲60.0%
₹10 Cr
▼28.6%
₹14 Cr
▼57.6%
₹33 Cr
▼67.6%
₹102 Cr
▼28.2%
₹142 Cr
Other Assets
₹399 Cr
▲17.0%
₹341 Cr
▲7.9%
₹316 Cr
▼7.1%
₹340 Cr
▼22.7%
₹440 Cr
▼32.0%
₹647 Cr
▲48.1%
₹437 Cr
▲46.6%
₹298 Cr
▲38.0%
₹216 Cr
▲29.3%
₹167 Cr
Total Assets
₹2.0K Cr
▲7.2%
₹1.9K Cr
▲20.2%
₹1.5K Cr
▲3.5%
₹1.5K Cr
▼1.7%
₹1.5K Cr
▲52.1%
₹1.0K Cr
▲33.3%
₹750 Cr
▲36.4%
₹550 Cr
▲4.6%
₹526 Cr
▲2.7%
₹512 Cr

Values in ₹ Cr · Source: Screener.in

Cash Flow Statement

ItemMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016
Operating CF
₹263 Cr
▼0.4%
₹264 Cr
▲6.9%
₹247 Cr
▼2.4%
₹253 Cr
▲1.6%
₹249 Cr
▲15.8%
₹215 Cr
▲138.9%
₹90 Cr
▼13.5%
₹104 Cr
▲2.0%
₹102 Cr
▲12.1%
₹91 Cr
Investing CF
₹-199 Cr
▼123.6%
₹-89 Cr
▼285.4%
₹48 Cr
▲106.5%
₹-736 Cr
▼1268.3%
₹63 Cr
▲160.6%
₹-104 Cr
▼388.9%
₹36 Cr
▲3500.0%
₹1 Cr
▲101.2%
₹-86 Cr
▼189.6%
₹96 Cr
Financing CF
₹-87 Cr
▲51.9%
₹-181 Cr
▲38.0%
₹-292 Cr
▼279.1%
₹163 Cr
▲593.9%
₹-33 Cr
▲40.0%
₹-55 Cr
▲53.4%
₹-118 Cr
▼35.6%
₹-87 Cr
▼411.8%
₹-17 Cr
▲90.2%
₹-174 Cr
Net Cash Flow
₹-23 Cr
▼283.3%
₹-6 Cr
▼300.0%
₹3 Cr
▲100.9%
₹-321 Cr
▼215.1%
₹279 Cr
▲398.2%
₹56 Cr
▲600.0%
₹8 Cr
▼55.6%
₹18 Cr
▲1900.0%
₹-1 Cr
▼107.1%
₹14 Cr
Free Cash Flow
₹196 Cr
▼2.0%
₹200 Cr
▲2.6%
₹195 Cr
▼12.6%
₹223 Cr
▲0.9%
₹221 Cr
▲23.5%
₹179 Cr
▲167.2%
₹67 Cr
▼25.6%
₹90 Cr
▲100.0%
₹45 Cr
▼43.0%
₹79 Cr

Values in ₹ Cr · Source: Screener.in

Key Ratios History

MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016
Debtor Days
41d
▲7.9%
38d
▼2.6%
39d
▼2.5%
40d
▼11.1%
45d
▼18.2%
55d
▼16.7%
66d
▲15.8%
57d
▲5.6%
54d
▲0.0%
54d
Inventory Days
65d
▲12.1%
58d
▼9.4%
64d
▼5.9%
68d
▲15.3%
59d
▲34.1%
44d
▼20.0%
55d
▲3.8%
53d
▲39.5%
38d
▼17.4%
46d
Days Payable
171d
▲14.0%
150d
▲10.3%
136d
▲0.0%
136d
▼15.0%
160d
▲5.3%
152d
▲68.9%
90d
▲2.3%
88d
▼9.3%
97d
▲1.0%
96d
Cash Conv. Cycle
-65d
▼22.6%
-53d
▼60.6%
-33d
▼13.8%
-29d
▲48.2%
-56d
▼3.7%
-54d
▼280.0%
30d
▲42.9%
21d
▲520.0%
-5d
▼266.7%
3d
Working Capital Days
-18d
▼12.5%
-16d
▲27.3%
-22d
▲15.4%
-26d
▼188.9%
-9d
▼550.0%
2d
▼93.9%
33d
▲17.9%
28d
▲203.7%
-27d
▼437.5%
8d
ROCE
15.0%
▼6.3%
16.0%
▼5.9%
17.0%
▼41.4%
29.0%
▼19.4%
36.0%
▼10.0%
40.0%
▼7.0%
43.0%
▲0.0%
43.0%
▼6.5%
46.0%
▲35.3%
34.0%

Source: Screener.in · Lower days = better efficiency

Related Analysis

Same Sector

ALKEM
Alkem Laboratories Limited
Neutral
APOLLOHOSP
Apollo Hospitals Enterprise Limited
Neutral
AUROPHARMA
Aurobindo Pharma Limited
Neutral
BIOCON
Biocon Limited
Neutral
CIPLA
Cipla Limited
Neutral

Frequently Asked Questions

What is Metropolis Healthcare Limited share price today?▾
Metropolis Healthcare Limited (METROPOLIS) is currently trading at ₹568.8 on NSE, down 0.86% as of the last market session. Prices update daily after market close on MarketNetra.
Is Metropolis Healthcare Limited available in F&O (Futures & Options)?▾
Yes, Metropolis Healthcare Limited (METROPOLIS) is part of the NSE F&O segment with a lot size of 1 shares. Options are available with monthly expiry contracts. You can track the full option chain and OI analysis on MarketNetra.
What is Metropolis Healthcare Limited 52-week high and low?▾
Metropolis Healthcare Limited's 52-week high is ₹600 and the 52-week low is ₹412. The current price of ₹568.8 is 5.2% below the 52W high.
What is Metropolis Healthcare Limited P/E ratio?▾
Metropolis Healthcare Limited's current P/E ratio is 57.6. This indicates the market is paying ₹57.6 for every ₹1 of earnings. Compare this to the sector average to assess relative valuation.
How to trade Metropolis Healthcare Limited options?▾
Metropolis Healthcare Limited options are traded on NSE with monthly expiry contracts (lot size: 1 shares). To trade METROPOLIS options: select your expiry on the option chain page, identify key OI strikes, check the PCR and buildup type on OI analysis, and review FII/DII flows for institutional sentiment before taking a position.